Mirae Asset Private Equity is a private equity general partner firm headquartered in Seoul, South Korea.
BiomX, an Israel-based microbiome therapeutics company, raised $24m in a Series A from OrbiMed, and others.
TX-based development stage biotechnology company ImmunoMet Therapeutics has raised $5.0m in Series B from Intervest and others.
Althea, a South Korean cosmetics e-commerce site, closed a $3.5m Series A round from Mirae Asset Ventures, Cherubic Ventures and others.
Read more news concerning Mirae Asset Private Equity
A sampling of Mirae Asset Private Equity portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?